Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_provenance.
- NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_assertion description "[In vitro and in vivo functional studies, including the use of antisense antagomir oligonucleotides, confirmed the key role of miR-221/-222 in regulating the progression of human melanoma; this suggests that targeted therapies suppressing miR-221/-222 may prove beneficial in advanced melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_provenance.
- NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_assertion evidence source_evidence_literature NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_provenance.
- NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_assertion SIO_000772 18417445 NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_provenance.
- NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_assertion wasDerivedFrom befree-2016 NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_provenance.
- NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_assertion wasGeneratedBy ECO_0000203 NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_provenance.
- befree-2016 importedOn "2016-02-19" NP666385.RAZ2eFLytb45M5Ch3aHY82yj4viY-tYr9HRDMlEXCKY_0130_provenance.